Delivery Order SPE2DE24D0013-SPE2D626F330V

The Defense Logistics Agency Medical Supply Chain awarded a $14,960 firm fixed-price delivery order to Cepheid Inc. on November 20, 2025, with an ultimate completion date of December 5, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, represents a relatively modest procurement within Cepheid's broader federal contracting portfolio and likely involves molecular diagnostic reagents or test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation, indicating it was awarded through competitive procurement. The place of performance is located at Cepheid's headquarters in Sunnyvale, California.

Cepheid is a recognized leader in federal molecular diagnostics procurement, with an established track record serving multiple defense and civilian healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at approximately $6.7 million and $32.8 million respectively, which establish the contracting framework for extensive ongoing procurement of diagnostic solutions across the federal healthcare system. This delivery order represents routine ordering activity under the DLA Medical Supply Chain's procurement processes and aligns with the Defense Department's continued reliance on rapid molecular testing capabilities for infectious disease detection across military medical facilities and defense personnel.